Insider · CIK 0001834418

Lecault Veronique

Reports to the SEC for 1 company · VANCOUVER, A1

sec.gov

Transactions

Companies

Filings

CIK

0001834418

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-01	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director, Chief Technology Officer	AAward	+539K sh	—	—	5,201,069
2025-01-01	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director, Chief Technology Officer	AAward	+832K sh	—	—	4,661,804
2024-06-21	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+83.3K sh	$0.19	+$15.7K	2,123,456
2024-06-21	ABCLAbCellera Biologics Inc. · Share option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	−83.3K sh	—	—	3,829,771
2024-01-14	ABCLAbCellera Biologics Inc. · Share option (right to buy)A Award	Director, Chief Technology Officer	AAward	+770K sh	—	—	3,913,105
2023-09-12	ABCLAbCellera Biologics Inc.P Purchase	Director, Chief Technology Officer	PPurchase	+20K sh	$5.19	+$104K	2,040,122
2023-05-05	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+250K sh	$0.19	+$47.5K	2,020,122
2023-05-05	ABCLAbCellera Biologics Inc. · Share option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	−250K sh	—	—	3,142,689
2022-12-01	ABCLAbCellera Biologics Inc. · Share Options (right to buy)A Award	Director, Chief Technology Officer	AAward	+463K sh	—	—	3,392,689
2022-05-16	ABCLAbCellera Biologics Inc.P Purchase	Director, Chief Technology Officer	PPurchase	+200K sh	$6.34	+$1.27M	1,770,122
2022-02-28	ABCLAbCellera Biologics Inc.P Purchase	Director, Chief Technology Officer	PPurchase	+231K sh	$8.66	+$2M	1,570,122
2021-12-08	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+250K sh	$0.19	+$47.5K	1,589,333
2021-12-08	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	−250K sh	—	—	2,524,134
2021-12-08	ABCLAbCellera Biologics Inc.G Gift	Director, Chief Technology Officer	GGift	−250K sh	—	—	1,339,333
2021-12-07	ABCLAbCellera Biologics Inc. · Share OptionA Award	Director, Chief Technology Officer	AAward	+406K sh	—	—	2,930,154
2021-11-30	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+83.3K sh	$14.96	+$1.25M	1,422,666
2021-11-30	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	−83.3K sh	—	—	2,774,134
2021-11-30	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+83.3K sh	$0.19	+$15.8K	1,422,666
2021-11-30	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+83.3K sh	—	—	2,774,134
2021-11-30	ABCLAbCellera Biologics Inc.G Gift	Director, Chief Technology Officer	GGift	−83.3K sh	—	—	1,339,333
2021-06-15	ABCLAbCellera Biologics Inc.M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	+333K sh	$0.19	+$63.3K	1,339,333
2021-06-15	ABCLAbCellera Biologics Inc. · Share Option (right to buy)M Exercise/Conversion	Director, Chief Technology Officer	MExercise/Conversion	−333K sh	—	—	666,667
2021-06-09	ABCLAbCellera Biologics Inc.S Sale	Director, Chief Technology Officer	SSale	−1M sh	$25.50	−$25.5M	273,630
2020-12-15	ABCLAbCellera Biologics Inc.P Purchase	Director, Chief Technology Officer	PPurchase	+6,000 sh	$20.00	+$120K	1,006,000
2020-12-15	ABCLAbCellera Biologics Inc.P Purchase	Director, Chief Technology Officer	PPurchase	+17K sh	$20.00	+$340K	61,580
2020-12-10	ABCLAbCellera Biologics Inc. · Stock Option (right to buy)A Award	Director, Chief Technology Officer	AAward	+191K sh	—	—	190,800
2020-10-29	ABCLAbCellera Biologics Inc. · Stock Option (right to buy)A Award	Director, Chief Technology Officer	AAward	+2M sh	—	—	2,000,000

Recent filings

Accepted (ET)
Jan 54
Lecault Veronique0001834418-26-000002
SEC(opens sec.gov)
Jan 34
Lecault Veronique0001628280-25-000235
SEC(opens sec.gov)
Jun 244
Lecault Veronique0001628280-24-029675
SEC(opens sec.gov)
Jan 164
Lecault Veronique0001703057-24-000008
SEC(opens sec.gov)
Sep 144
Lecault Veronique0001703057-23-000030
SEC(opens sec.gov)
May 94
Lecault Veronique0001209191-23-028214
SEC(opens sec.gov)
Dec 54
Lecault Veronique0001209191-22-059573
SEC(opens sec.gov)
May 174
Lecault Veronique0001209191-22-029542
SEC(opens sec.gov)
Mar 14
Lecault Veronique0001209191-22-014395
SEC(opens sec.gov)
Feb 35
Lecault Veronique0001209191-22-006972
SEC(opens sec.gov)
Dec 94
Lecault Veronique0001209191-21-068851
SEC(opens sec.gov)
Dec 94
Lecault Veronique0001209191-21-068844
SEC(opens sec.gov)
Dec 34/A
Lecault Veronique0001209191-21-067941
SEC(opens sec.gov)
Dec 24
Lecault Veronique0001209191-21-067491
SEC(opens sec.gov)

Companies

AbCellera Biologics Inc.Director, Chief Technology OfficerABCL

Address

C/O ABCELLERA BIOLOGICS INC 150 W 4TH AVENUE

VANCOUVER, A1